Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2679 | 2175 | 44.4 | 83% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
139 | 3 | THYROID//THYROID CANCER//GRAVES DISEASE | 64904 |
1241 | 2 | THYROID HORMONE//THYROID HORMONE RECEPTOR//DEIODINASE | 9025 |
2679 | 1 | THYROID HORMONE RECEPTOR//RESISTANCE TO THYROID HORMONE//V ERBA | 2175 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | THYROID HORMONE RECEPTOR | authKW | 1114085 | 10% | 38% | 208 |
2 | RESISTANCE TO THYROID HORMONE | authKW | 584878 | 2% | 83% | 50 |
3 | V ERBA | authKW | 269510 | 1% | 80% | 24 |
4 | THYROID HORMONE RESISTANCE | authKW | 265849 | 1% | 76% | 25 |
5 | THYROMIMETICS | authKW | 200524 | 1% | 71% | 20 |
6 | THYROID HORMONE RECEPTOR BETA | authKW | 197189 | 1% | 59% | 24 |
7 | MOL REGULAT NEUROENDOCRINOL SECT | address | 175463 | 1% | 83% | 15 |
8 | JP KENNEDY JR MENTAL RETARDAT | address | 143732 | 1% | 64% | 16 |
9 | THYROID HORMONE RESPONSE ELEMENT | authKW | 103134 | 1% | 57% | 13 |
10 | THYROID HORMONE RECEPTOR MUTANTS | authKW | 99820 | 0% | 89% | 8 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 25856 | 42% | 0% | 914 |
2 | Biochemistry & Molecular Biology | 3633 | 36% | 0% | 780 |
3 | Cell Biology | 2978 | 20% | 0% | 441 |
4 | Biophysics | 272 | 5% | 0% | 112 |
5 | Genetics & Heredity | 158 | 5% | 0% | 109 |
6 | Oncology | 81 | 5% | 0% | 118 |
7 | Chemistry, Medicinal | 78 | 3% | 0% | 56 |
8 | Medicine, Research & Experimental | 47 | 3% | 0% | 65 |
9 | Developmental Biology | 18 | 1% | 0% | 21 |
10 | Physiology | 13 | 2% | 0% | 42 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL REGULAT NEUROENDOCRINOL SECT | 175463 | 1% | 83% | 15 |
2 | JP KENNEDY JR MENTAL RETARDAT | 143732 | 1% | 64% | 16 |
3 | JOSEPH P KENNEDY JR MENTAL RETARDAT | 56604 | 1% | 37% | 11 |
4 | PHARMACEUT CHEM MOL CELLULAR PHARMACOL | 56150 | 0% | 100% | 4 |
5 | PROD SAFETY S | 37431 | 0% | 67% | 4 |
6 | THYROID STUDY UNIT | 34833 | 1% | 21% | 12 |
7 | PENN DIABET | 32030 | 1% | 21% | 11 |
8 | MOL ENDOCRINOL PHYSIOL | 31583 | 0% | 75% | 3 |
9 | MED THYROID STUDY UNIT | 28650 | 0% | 29% | 7 |
10 | CLIN ENDOCRINOL BRANCH | 26574 | 1% | 8% | 23 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOLECULAR ENDOCRINOLOGY | 74688 | 8% | 3% | 173 |
2 | THYROID | 27484 | 4% | 2% | 85 |
3 | MOLECULAR AND CELLULAR ENDOCRINOLOGY | 11358 | 4% | 1% | 84 |
4 | ENDOCRINOLOGY | 10813 | 6% | 1% | 139 |
5 | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 3679 | 4% | 0% | 80 |
6 | JOURNAL OF MOLECULAR ENDOCRINOLOGY | 3516 | 1% | 1% | 23 |
7 | JOURNAL OF BIOLOGICAL CHEMISTRY | 3250 | 9% | 0% | 194 |
8 | MOLECULAR AND CELLULAR BIOLOGY | 2649 | 3% | 0% | 66 |
9 | TRENDS IN ENDOCRINOLOGY AND METABOLISM | 1575 | 1% | 1% | 14 |
10 | JOURNAL OF ENDOCRINOLOGY | 1572 | 1% | 0% | 31 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | YEN, PM , (2001) PHYSIOLOGICAL AND MOLECULAR BASIS OF THYROID HORMONE ACTION.PHYSIOLOGICAL REVIEWS. VOL. 81. ISSUE 3. P. 1097 -1142 | 260 | 48% | 946 |
2 | ORTIGA-CARVALHO, TM , SIDHAYE, AR , WONDISFORD, FE , (2014) THYROID HORMONE RECEPTORS AND RESISTANCE TO THYROID HORMONE DISORDERS.NATURE REVIEWS ENDOCRINOLOGY. VOL. 10. ISSUE 10. P. 582 -591 | 78 | 78% | 23 |
3 | REFETOFF, S , WEISS, RE , USALA, SJ , (1993) THE SYNDROMES OF RESISTANCE TO THYROID-HORMONE.ENDOCRINE REVIEWS. VOL. 14. ISSUE 3. P. 348-399 | 123 | 66% | 510 |
4 | LAZAR, MA , (1993) THYROID-HORMONE RECEPTORS - MULTIPLE FORMS, MULTIPLE POSSIBILITIES.ENDOCRINE REVIEWS. VOL. 14. ISSUE 2. P. 184-193 | 100 | 68% | 774 |
5 | ASTAPOVA, I , (2016) ROLE OF CO-REGULATORS IN METABOLIC AND TRANSCRIPTIONAL ACTIONS OF THYROID HORMONE.JOURNAL OF MOLECULAR ENDOCRINOLOGY. VOL. 56. ISSUE 3. P. R73 -R97 | 110 | 60% | 0 |
6 | JOHARAPURKAR, AA , DHOTE, VV , JAIN, MR , (2012) SELECTIVE THYROMIMETICS USING RECEPTOR AND TISSUE SELECTIVITY APPROACHES: PROSPECTS FOR DYSLIPIDEMIA.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 55. ISSUE 12. P. 5649 -5675 | 99 | 62% | 10 |
7 | LEE, S , PRIVALSKY, ML , (2005) MULTIPLE MUTATIONS CONTRIBUTE TO REPRESSION BY THE V-ERB A ONCOPROTEIN.ONCOGENE. VOL. 24. ISSUE 45. P. 6737-6752 | 77 | 90% | 7 |
8 | ZHANG, JS , LAZAR, MA , (2000) THE MECHANISM OF ACTION OF THYROID HORMONES.ANNUAL REVIEW OF PHYSIOLOGY. VOL. 62. ISSUE . P. 439-466 | 101 | 48% | 423 |
9 | FLAMANT, F , GAUTHIER, K , SAMARUT, J , (2007) THYROID HORMONES SIGNALING IS GETTING MORE COMPLEX: STORMS ARE COMING.MOLECULAR ENDOCRINOLOGY. VOL. 21. ISSUE 2. P. 321-333 | 92 | 57% | 54 |
10 | WU, SM , CHENG, WL , LIN, CD , LIN, KH , (2013) THYROID HORMONE ACTIONS IN LIVER CANCER.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 70. ISSUE 11. P. 1915 -1936 | 90 | 52% | 3 |
Classes with closest relation at Level 1 |